| Dr Eric Mckenzie Greber, MD | |
|
726 N Acadia Rd Ste 1000, Thibodaux, LA 70301-5009 | |
| (985) 625-2200 | |
| (985) 625-2206 |
| Full Name | Dr Eric Mckenzie Greber |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 13 Years |
| Location | 726 N Acadia Rd Ste 1000, Thibodaux, Louisiana |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225320906 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Home Health Ctr Of Thibodaux | Thibodaux, LA | Home health agency |
| Thibodaux Regional Medical Center | Thibodaux, LA | Hospital |
| Physicians Medical Center | Houma, LA | Hospital |
| Franklin Foundation Hospital | Franklin, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cla Care Of La Iii Llc | 0345571584 | 6 |
| Hospital Service District No 1 Of The Parish Of St Mary | 6800782541 | 24 |
| Orthopaedic Sports Specialists Of Louisiana Llc | 5991893869 | 21 |
News Archive
Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
The National Cancer Institute has awarded UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center its highest designation, making it one of only 45 cancer centers nationally to receive this distinction over the past 44 years.
› Verified 6 days ago
| Entity Name | Houma Orthopedic Clinic Amc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215940929 PECOS PAC ID: 4183683923 Enrollment ID: O20041007000010 |
News Archive
Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
The National Cancer Institute has awarded UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center its highest designation, making it one of only 45 cancer centers nationally to receive this distinction over the past 44 years.
› Verified 6 days ago
| Entity Name | Hospital Service District No 1 Of The Parish Of St Mary |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1699895953 PECOS PAC ID: 6800782541 Enrollment ID: O20050119000730 |
News Archive
Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
The National Cancer Institute has awarded UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center its highest designation, making it one of only 45 cancer centers nationally to receive this distinction over the past 44 years.
› Verified 6 days ago
| Entity Name | Orthopaedic Sports Specialists Of Louisiana Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316146228 PECOS PAC ID: 5991893869 Enrollment ID: O20071112000318 |
News Archive
Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
The National Cancer Institute has awarded UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center its highest designation, making it one of only 45 cancer centers nationally to receive this distinction over the past 44 years.
› Verified 6 days ago
| Entity Name | Eric M. Greber, Md Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164946315 PECOS PAC ID: 0446523914 Enrollment ID: O20170905001494 |
News Archive
Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
The National Cancer Institute has awarded UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center its highest designation, making it one of only 45 cancer centers nationally to receive this distinction over the past 44 years.
› Verified 6 days ago
| Entity Name | Cla Care Of La Iii Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336602101 PECOS PAC ID: 0345571584 Enrollment ID: O20191018002101 |
News Archive
Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
The National Cancer Institute has awarded UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center its highest designation, making it one of only 45 cancer centers nationally to receive this distinction over the past 44 years.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eric Mckenzie Greber, MD Po Box 28, Thibodaux, LA 70302-0028 Ph: (985) 625-2200 | Dr Eric Mckenzie Greber, MD 726 N Acadia Rd Ste 1000, Thibodaux, LA 70301-5009 Ph: (985) 625-2200 |
News Archive
Ingen Technologies, Inc. (Pink Sheets:IGNT), an emerging medical device manufacturer developing innovative solutions for the respiratory market, with a new patented and proprietary medical product line targeting the $8B respiratory market, announced today that the company has also filed a U.S patent and will begin the required manufacturing processes to produce the new drug insulin thermos product.
A risk-management program set up in 2012 by the U.S. Food and Drug Administration to curb improper prescribing of extended-release and long-acting opioids may not have been effective because of shortcomings in the program's design and execution, according to a paper from researchers at the Johns Hopkins Bloomberg School of Public Health.
Boston Scientific Corporation today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and CE Mark approval to market its WallFlex® Fully Covered Esophageal Stent for the treatment of malignant esophageal strictures (obstructions) caused by tumors in patients with resectable or non-resectable esophageal cancer.
The National Cancer Institute has awarded UT Southwestern Medical Center's Harold C. Simmons Comprehensive Cancer Center its highest designation, making it one of only 45 cancer centers nationally to receive this distinction over the past 44 years.
› Verified 6 days ago
John Christian Hildenbrand Iv, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 726 N Acadia Rd, Suite 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 | |
Dr. Richard A Morvant Jr., M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 726 N Acadia Rd, Suite 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 | |
Dr. David Wadie Elias, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 726 N Acadia Rd, Suite 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 | |
Neil James Maki, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 525 Saint Mary St, Thibodaux, LA 70301 Phone: 985-446-6824 | |
Dr. Patrick Roan Ellender, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 726 N Acadia Rd, Suite 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 | |
Dr. Jason A. Higgins, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 726 N Acadia Rd, Suite 1000, Thibodaux, LA 70301 Phone: 985-625-2200 Fax: 985-625-2206 |